Requests that the FDA declare that Cyproheptadine HCL Tablets, 3 mg and 6 mg, are suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2026-P-5978
Documents
7
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Supporting & Related Material· May 27, 2026
- Supporting & Related Material· May 27, 2026